From the Vault: Hair Density, Shedding, and Quality-of-Life Measures in Peri- and Post-Menopausal Women
Female pattern hair loss and age-related thinning present a widespread clinical challenge, with estimates showing that up to 80% of women experience notable hair loss by age 60. While initial therapeutic trials often focus on short-term outcomes, demonstrating long-term safety, sustained efficacy, and systemic quality-of-life benefits is critical when counseling peri- and post-menopausal patients.
We are pulling an article from the JDD Vault that details the results of a 6-month open-label extension phase following an initial randomized, double-blind, placebo-controlled trial evaluating a novel oral nutraceutical supplement. Across a full 12 months of active treatment, subjects experienced progressive, incremental improvements in hair growth, hair quality, and reduced shedding, while placebo-crossover participants achieved significant increases in objective hair counts upon initiating daily supplementation.
Beyond hair density, the extended study demonstrated notable secondary benefits, including improvements in reported menopausal symptoms and overall quality-of-life metrics. These findings support the long-term utility of targeted nutraceutical therapy as a well-tolerated, durable adjunct for managing female hair thinning.
Read the full article to review the detailed 12-month data, clinical trial metrics, and patient satisfaction scores.
Blog write-up assisted by AI
